Loading clinical trials...
Loading clinical trials...
The purpose of this study is to use an immunologic approach following the treatment for recurrent disease in patients with ovarian, fallopian tube, or peritoneal cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AGO Study Group
NCT07042802 · Ovarian Cancer
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06997029 · Advanced Solid Tumor, Advanced Breast Cancer, and more
Clinic for Gynecology and Gyn. Oncology, Humboldt University
Berlin
University Clinic Carl Gustav Carus, Gynecological hospital
Dresden
Gynecologic Hospital
Düsseldorf
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions